Symptoms in 400 patients referred to palliative care services: Prevalence and patterns

Palliative Medicine

Volumn 17, Issue 4, 2003, Pages 310-314

  Potter, Jean ^a   Hami, Faeqa ^b   Bryan, Tamsin ^c   Quigley, Columba ^d  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Cancer; Palliative care; Prevalence; Symptom burden; Symptoms

Indexed keywords

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CHILD; CONSTIPATION; CONTROLLED STUDY; DEMOGRAPHY; DYSPNEA; FEMALE; HEALTH CARE PLANNING; HOSPITAL PATIENT; HOSPITAL SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NATIONAL HEALTH SERVICE; OUTPATIENT CARE; PAIN; PATIENT REFERRAL; PREVALENCE; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANOREXIA; ASTHENIA; CHILD; CONSTIPATION; DYSPNEA; FEMALE; HUMANS; LONDON; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PALLIATIVE CARE; PREVALENCE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 0038001585     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216303pm760oa     Document Type: Article

References (21)

1. The NHS Cancer Plan. London: Department of Health, September 2000.
2. World Health Organisation. Cancer pain relief and palliative care: report of a WHO Expert Committee. Geneva: WHO, 1990.
3. NHS Executive - London Region. Strategic framework for improving palliative care. January 2001.
4. Hockley J, Dunlop R, Davies RJ. Survey of distressing symptoms in dying patients and their families in hospital and the response of the symptom control teams. BMJ 1988; 296: 1715-17.
5. Schuitt KW, Sleifer DT, Meijler WJ. Symptoms and functional status of patients with disseminated cancer visiting outpatient departments. J Pain Symptom Manage 1998; 16: 290-97.
6. Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 1994; 9: 372-82.
7. Krech R, Davis J, Walsh D, Curtis EB. Symptoms of lung cancer. Palliat Med 1992; 6: 309-15.
8. Krech R, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage 1991; 6: 360-67.
9. Ellershaw J, Peat SJ, Boys LC. Assessing the effectiveness of a hospital palliative care team. Palliat Med 1995; 9: 145-52.
10. Jenkins JA, Taube AW, Turner K. Initial demographic symptom and medication profiles in patients admitted to continuing palliative care units. J Pain Symptom Manage 1998; 16: 163-70.
11. McIlmurray MB, Warren MR. Evaluation of a new hospice: the relief of symptoms in cancer patients in the first year. Palliat Med 1989; 31: 35-40.
12. Ng K, von Gunten CF. Symptoms and attitudes of 100 consecutive patients admitted to an acute hospice/palliative care unit. J Pain Symptom Manage 1998; 16: 307-16.
13. Conill C, Verger E, Henriques I. Symptom prevalence in the last week of life. J Pain Symptom Manage 1998; 16: 328-31.
14. Dunphy KP. A comparison of hospice and homecare patients: patterns of referral, patient characteristics and predictors of death. Palliat Med 1990; 4: 105-11.
15. Coyle N, Adelhardt J, Foley KM, Portenoy RK. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage 1990; 5: 83-93.
16. National Statistics. Mortality statistics: review of the registrar general on deaths by cause sex and age in England and Wales 1999. London: The Stationery Office, 1999.
17. Vainio A, Auvinen A, with members of the Symptom Prevalence Group. Prevalence of symptoms among patients with advanced cancer. J Pain Symptom Manage 1996; 12: 3-10.
18. Hearn J, Higginson I. Epidemiology of cancer pain. London: UKCCR, 2000.
19. Donnelly S, Walsh D. The symptoms of advanced cancer: identification of clinical research priorities by assessment of prevalence and severity. J Pall Care 1995; 11: 27-32.
20. Lelli G, Angelelli B, Giambiasi ME. The anabolic effect of high dose medroxyprogesterone acetate in oncology. Pharmacol Res Comm 1983; 15: 561-68.
21. Wachtel T, Allen-Masterston A, Reuben D, Goldber R, Mor V. The end stage cancer patient: terminal common pathway. Hospice J 1998; 4: 43-81.